This novel vaccination method, but not control vaccination (irradiated B16-MRP1 cells decorated with unconjugated aptamers), elicited a strong immune response (increased T cell proliferation and IFNγ production) and inhibited subsequent tumor growth in vivo. The gene discussed is IFNG; the disease is neoplasm.